Search Results - "Kleintjens, Joris"

A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France by Nieland, Kaspar, Labbé, Antoine, Schweitzer, Cedric, Gicquel, Gaetan, Kleintjens, Joris, Ostawal, Amrita, Treur, Maarten, Falvey, Heather

“…To investigate the cost-effectiveness of implementing iStent inject trabecular bypass stent (TBS) in conjunction with cataract surgery (Cat Sx) in patients…”
Get full text

The Economic Impact and Cost-Effectiveness of Urinary Neutrophil Gelatinase-Associated Lipocalin After Cardiac Surgery by Shaw, Andrew D., MBBS, FRCA, Chalfin, Donald B., MD, MS, FCCM, Kleintjens, Joris, MSc

“…Abstract Background Acute kidney injury (AKI) is common after cardiac surgery, and expeditious recognition with specific biomarkers may help improve outcome…”
Get full text

A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France by Kaspar Nieland, Antoine Labbé, Cedric Schweitzer, Gaetan Gicquel, Joris Kleintjens, Amrita Ostawal, Maarten Treur, Heather Falvey

“…ObjectiveTo investigate the cost-effectiveness of implementing iStent inject trabecular bypass stent (TBS) in conjunction with cataract surgery (Cat Sx) in…”
Get full text

Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy by Akpo, Essè Ifèbi Hervé, Cerri, Karin, Kleintjens, Joris

“…Objectives Studies on medical resource utilization (MRU) and related costs are important for evaluating the potential patient management and cost-effectiveness…”
Get full text

Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting by Kleintjens, Joris, Li, Xiao, Simoens, Steven, Thijs, Vincent, Goethals, Marnix, Rietzschel, Ernst R., Asukai, Yumi, Saka, Ömer, Evers, Thomas, Faes, Petra, Vansieleghem, Stefaan, De Ruyck, Mimi

“…Background Warfarin, an inexpensive drug that has been available for over half a century, has been the mainstay of anticoagulant therapy for stroke prevention…”
Get full text

Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients by Akpo, Essè Ifèbi Hervé, Sbarigia, Urbano, Wan, George, Kleintjens, Joris

“…Objective Limited evidence is available on predictors of medical resource utilization (MRU) and related direct costs, especially in treatment-experienced…”
Get full text

Implications of a Data-Driven Approach to Treatment with Growth Hormone in Children with Growth Hormone Deficiency and Turner Syndrome by Kaspers, Stefan, Ranke, Michael B., Han, Donald, Loftus, Jane, Wollmann, Hartmut, Lindberg, Anders, Roelants, Mathieu, Kleintjens, Joris

“…Background Response to growth hormone (GH) therapy may vary between individual patients. Therefore the use of GH in children should be closely monitored to…”
Get full text